{
    "overall_score": 71,
    "status": "needs_revision",
    "sub_scores": {
        "factual_accuracy": 92,
        "citation_consistency": 92,
        "logical_adequacy": 92,
        "tone_professionalism": 90,
        "hallucination_risk": 7
    },
    "issues": [
        {
            "id": "ISSUE-1",
            "severity": "high",
            "location_in_letter": {
                "sentence_index": 0
            },
            "description": "Unsupported claim: '[Your Name/Barrister Agent Name]\n[Your Title]\n[Your Law Firm/Agency Name]\n[Your Address]\n[Your Phone Number]\n[Your Email Address]\n\n[Date]\n\nAppeals Department\n[Insurer Name]\n[Insurer Address]\n\n**Subject: Formal Appeal for Denial of Genomic Sequencing for Early Cancer Detection for [Patient Name], Policy ID: [Patient's Policy ID], Claim Number: [Claim Number], Date of Service: [Date of Service]**\n\nDear Appeals Department,\n\nThis letter serves as a formal and urgent appeal regarding the denial of coverage for Genomic Sequencing for Early Cancer Detection for our client, [Patient Name], under policy ID [Patient's Policy ID].'",
            "evidence_refs": [],
            "suggested_fix": "Add clinical, legal, or denial evidence to support this claim."
        },
        {
            "id": "ISSUE-2",
            "severity": "medium",
            "location_in_letter": {
                "sentence_index": 2
            },
            "description": "Partially supported claim: 'The insurer's stated reason for denial is: \"We determine that the requested procedure, Genomic Sequencing for Early Cancer Detection, is experimental, unproven, and therefore non-covered under the terms of your policy.\" This determination cites the policy clause: \"Coverage is limited to those services, treatments, and supplies that are medically necessary, provided they are not considered experimental, investigative, or unproven by generally accepted medical standards.\"\n\nWe unequivocally dispute this characterization.'. Missing: clinical evidence.",
            "evidence_refs": [
                "The requested genomic sequencing was deemed experimental and therefore non-covered.",
                "IRDAI Regulation 4.3",
                "Policy Clause 4.2"
            ],
            "suggested_fix": "Strengthen this claim by citing the missing evidence sources."
        },
        {
            "id": "ISSUE-3",
            "severity": "medium",
            "location_in_letter": {
                "sentence_index": 6
            },
            "description": "Partially supported claim: '**Utility in Early Biomarker Identification for Lung Cancer:** A recent clinical study, \"Saliva-microbiome-derived signatures for early lung cancer detection\" (Ref: 2024-001), investigated the application of 16S rRNA amplicon sequencing on saliva samples.'. Missing: denial evidence.",
            "evidence_refs": [
                "PMID:2024001",
                "PMID:2024002",
                "IRDAI Regulation 4.3",
                "Policy Clause 4.2"
            ],
            "suggested_fix": "Strengthen this claim by citing the missing evidence sources."
        },
        {
            "id": "ISSUE-4",
            "severity": "high",
            "location_in_letter": {
                "sentence_index": 10
            },
            "description": "Unsupported claim: '2.'",
            "evidence_refs": [],
            "suggested_fix": "Add clinical, legal, or denial evidence to support this claim."
        },
        {
            "id": "ISSUE-5",
            "severity": "medium",
            "location_in_letter": {
                "sentence_index": 11
            },
            "description": "Partially supported claim: '**Understanding Early Cancer Evolution and Guiding Treatment Strategies in Osteosarcoma:** Further supporting the clinical relevance of genomic sequencing, a study titled \"Genome sequencing for understanding early osteosarcoma evolution and guiding treatment\" (Ref: 2024-002) performed longitudinal genome-sequencing analysis on osteosarcoma patients.'. Missing: legal evidence.",
            "evidence_refs": [
                "The requested genomic sequencing was deemed experimental and therefore non-covered.",
                "PMID:2024001",
                "PMID:2024002"
            ],
            "suggested_fix": "Strengthen this claim by citing the missing evidence sources."
        },
        {
            "id": "ISSUE-6",
            "severity": "medium",
            "location_in_letter": {
                "sentence_index": 13
            },
            "description": "Partially supported claim: 'Crucially, the study revealed that the earliest and most clinically significant mutations originated no more than a year prior to the primary tumor's clinical detection.'. Missing: denial evidence.",
            "evidence_refs": [
                "PMID:2024001",
                "PMID:2024002",
                "IRDAI Regulation 4.3",
                "Policy Clause 4.2"
            ],
            "suggested_fix": "Strengthen this claim by citing the missing evidence sources."
        },
        {
            "id": "ISSUE-7",
            "severity": "medium",
            "location_in_letter": {
                "sentence_index": 17
            },
            "description": "Partially supported claim: 'It is instrumental in identifying biomarkers and mutations that precede clinical diagnosis, thereby facilitating earlier intervention and more targeted treatment approaches.'. Missing: denial evidence.",
            "evidence_refs": [
                "PMID:2024001",
                "PMID:2024002",
                "IRDAI Regulation 4.3",
                "Policy Clause 4.2"
            ],
            "suggested_fix": "Strengthen this claim by citing the missing evidence sources."
        },
        {
            "id": "ISSUE-8",
            "severity": "medium",
            "location_in_letter": {
                "sentence_index": 20
            },
            "description": "Partially supported claim: 'The denial of coverage for [Patient Name] is erroneous and represents an outdated interpretation of the available medical evidence.'. Missing: denial evidence.",
            "evidence_refs": [
                "PMID:2024001",
                "PMID:2024002",
                "IRDAI Regulation 4.3",
                "Policy Clause 4.2"
            ],
            "suggested_fix": "Strengthen this claim by citing the missing evidence sources."
        },
        {
            "id": "ISSUE-9",
            "severity": "medium",
            "location_in_letter": {
                "sentence_index": 25
            },
            "description": "Partially supported claim: 'Sincerely,\n\n[Your Name/Barrister Agent Name]\n[Your Title]\nBarrister Agent for [Patient Name]'. Missing: denial evidence.",
            "evidence_refs": [
                "PMID:2024001",
                "PMID:2024002",
                "IRDAI Regulation 4.3"
            ],
            "suggested_fix": "Strengthen this claim by citing the missing evidence sources."
        }
    ],
    "confidence_estimate": 0.85,
    "meta": {
        "generated_at": "2025-11-24T06:08:53.868698",
        "judge_agent_version": "v1.0"
    }
}